HMTXF
Price:
$0.0573
Market Cap:
$15.81M
Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the United States, as well as for the treatment of heart and peripheral arterial diseases. The company is also developing various types of cell products, such as synergetic cell populations and neural cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.
Industry
Biotechnology
IPO Date
2016-01-07
Stock Exchange
OTC
Ticker
HMTXF
According to Hemostemix Inc.’s latest financial reports and current stock price. The company's current ROE is 68.24%. This represents a change of 298.13% compared to the average of 17.14% of the last 4 quarters.
The mean historical ROE of Hemostemix Inc. over the last ten years is -243.58%. The current 68.24% ROE has changed -128.02% with respect to the historical average. Over the past ten years (40 quarters), HMTXF's ROE was at its highest in in the December 2020 quarter at 363.07%. The ROE was at its lowest in in the December 2015 quarter at -668.09%.
Average
-243.58%
Median
56.83%
Minimum
-2289.19%
Maximum
707.02%
Discovering the peaks and valleys of Hemostemix Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.69%
Maximum Annual ROE = 707.02%
Minimum Annual Increase = -174.40%
Minimum Annual ROE = -2289.19%
| Year | ROE | Change |
|---|---|---|
| 2024 | 36.31% | 6.98% |
| 2023 | 33.94% | -56.11% |
| 2022 | 77.34% | -34.99% |
| 2021 | 118.97% | -83.17% |
| 2020 | 707.02% | 487.27% |
| 2019 | 120.39% | -109.49% |
| 2018 | -1268.55% | 1.46% |
| 2017 | -81.34% | -174.40% |
| 2016 | 109.32% | -104.78% |
| 2015 | -2289.19% | 1.69% |
The current ROE of Hemostemix Inc. (HMTXF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
49.20%
5-year avg
194.72%
10-year avg
-243.58%
Hemostemix Inc.’s ROE is less than Nymox Pharmaceutical Corporation (24.07%), greater than Devonian Health Group Inc. (-33.54%), greater than HOOKIPA Pharma Inc. (-120.60%), greater than Algorae Pharmaceuticals Limited (-61.85%), less than EOM Pharmaceuticals Holdings, Inc. (59.97%), less than Sirona Biochem Corp. (221.45%), greater than Oxford BioDynamics Plc (-244.86%), greater than Inhibitor Therapeutics, Inc. (-337.95%), greater than Quest PharmaTech Inc. (-1.09%), less than Cell Source, Inc. (19.05%),
| Company | ROE | Market cap |
|---|---|---|
| 24.07% | $4.92M | |
| -33.54% | $10.55M | |
| -120.60% | $11.10M | |
| -61.85% | $8.27M | |
| 59.97% | $22.05M | |
| 221.45% | $5.60M | |
| -244.86% | $8.95M | |
| -337.95% | $8.63M | |
| -1.09% | $4.82M | |
| 19.05% | $17.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemostemix Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hemostemix Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Hemostemix Inc.'s ROE?
How is the ROE calculated for Hemostemix Inc. (HMTXF)?
What is the highest ROE for Hemostemix Inc. (HMTXF)?
What is the 3-year average ROE for Hemostemix Inc. (HMTXF)?
What is the 5-year average ROE for Hemostemix Inc. (HMTXF)?
How does the current ROE for Hemostemix Inc. (HMTXF) compare to its historical average?